| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Revenue | $4.38B | +2.8% |
| Cost of Revenue | $3.43B | +6.4% |
| Gross Profit | $953.0M | -8.4% |
| R&D Expense | $17.0M | -5.6% |
| SG&A Expense | $935.0M | +12.8% |
| Operating Income | -$749.0M | -359.5% |
| Pre-tax Income | -$1.03B | -200.3% |
| Income Tax | $16.0M | +118.6% |
| Net Income | -$1.04B | -307.4% |
| EPS (Basic) | -$5.76 | -305.6% |
| EPS (Diluted) | -$5.76 | -305.6% |
| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $289.0M | +3.2% |
| Accounts Receivable | $921.0M | -8.1% |
| Inventory | $574.0M | -26.1% |
| Current Assets | $2.60B | -11.0% |
| Total Assets | $9.75B | -7.2% |
| Current Liabilities | $1.03B | -6.1% |
| Long-term Debt | $4.86B | +12.6% |
| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $268.0M | +5.5% |
| Investing Cash Flow | -$327.0M | +65.8% |
| Financing Cash Flow | $74.0M | -85.8% |
| Total Liabilities |
| $6.15B |
| +7.3% |
| Stockholders' Equity | $3.60B | -24.5% |